CYSLTR1 and Alzheimer disease: The aforementioned studies on CysLT1R antagonism in AD explained the observed improved cognitive performance not only by the attenuation of apoptotic and inflammatory responses [120], including the modulation of microglia and CD8+ T-cells [91], but also by restoring mitochondrial respiratory enzyme complex activities [121].